AEROVATE THERAPEUTICS INC (AVTE) Stock Analyst Ratings
NASDAQ:AVTE - Nasdaq - US0080641071 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 49% to AVTE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.38. This target is -2.86% below the current price.
AVTE was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about AVTE.
In the previous month the buy percentage consensus was at a similar level.
AVTE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-06-18 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-06-18 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-06-18 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-06-18 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2024-06-17 | BTIG | Downgrade | Buy -> Neutral |
| 2024-06-17 | Jefferies | Downgrade | Buy -> Hold |
| 2024-06-06 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-22 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-14 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-03-01 | Guggenheim | Initiate | Buy |
| 2022-12-06 | BTIG | Upgrade | Neutral -> Buy |
| 2022-08-16 | BTIG | Downgrade | Buy -> Neutral |
| 2022-02-11 | BTIG | Initiate | Buy |
| 2021-07-26 | Cowen & Co. | Initiate | Outperform |
| 2021-07-26 | Wedbush | Initiate | Outperform |
| 2021-07-26 | Evercore ISI Group | Initiate | Outperform |
| 2021-07-26 | Jefferies | Initiate | Buy |